Navigation Links
Blood Flow Measurement Boosts Stent Outcomes
Date:1/14/2009

Technology reduces deaths, complications, but may be too costly for some centers, experts say

WEDNESDAY, Jan. 14 (HealthDay News) -- A sophisticated measure of blood flow to determine where artery-opening stents should be implanted is more effective than the X-ray examinations now commonly used, an international study finds.

The technique, measuring what's known as "fractional flow reserve" (FFR), is designed for people who have multiple blockages that require artery-opening procedures such as angioplasty, followed by implantation of the flexible tubes called stents, explained study co-author Dr. Nico H. J. Pijls, professor of cardiology at the Catharina Hospital in Eindhoven, the Netherlands.

Such multiple blockages are seen in about 60 percent of cases, said Pijls, a leader in development of the flow-measuring technology.

The team published their findings in the Jan. 16 issue of the New England Journal of Medicine. The research was funded in part by Radi Medical Systems, which makes the FFR device tested in the trial.

The study, carried out in 20 European and U.S. medical centers, compared patient outcomes for stent implants using either FFR measurements or angiography (X-ray images) in 1,005 people who underwent artery-opening procedures.

Over a year of follow-up, 13.2 percent of those whose stents were implanted by the FFR method died, had major coronary events such as heart attacks or needed new procedures, compared to 18.3 percent of those in the X-ray group.

The cost of their treatment was lower, averaging $5,332 for the FFR cases against $6,007 for the angiography-guided group. The lower cost was due in part to the use of fewer stents in the FFR cases, an average of 1.9 versus 2.7 stents in the angiography group.

That's a real advantage, Pijls said, because, "you can do it in a more refined way. There are fewer complications, because instead of shooting for all stenoses [blockages], you can use stents only on those that are dangerous for the patient."

The FFR technology is not currently available in many medical centers, however. Its initial cost is $20,000, with a charge of about $600 for each use. "But its use will definitely increase if you look at these results, which I call impressive," Pijls said.

FFR is measured by inserting a pressure sensor mounted on a guidewire to the site of blockages in the arteries. FFR equipment is marketed by St. Jude Medical.

"This will provide impetus for some catheter laboratories to buy it, but we don't use it on a routine basis," said Dr. Stephen G. Ellis, director of the cardiac catheterization laboratory at the Cleveland Clinic and author of an editorial accompanying the report.

FFR measurements were used to guide stent implants in about 10 percent of cases at the Cleveland Clinic in the past year, Ellis said. "I doubt if we will be using it in more than 25 percent of cases," he said.

Cost is an issue, he said, since "economic times are hard for hospitals now. We don't have enough data on costs. What we need is a U.S.-based study of the cost involved. One would assume that because it reduces the number of second procedures, that would offset the roughly $600 cost per case."

The group that did the study "is now doing a more extended cost-benefit analysis," Pijls said.

The new report probably will not lead to a surge in American use of the FFR technology, according to Ellis, but its use is bound to widen. "This is not a revolution but a devolution," he said. "It is logical to treat only blockages that are physiologically significant."

More information

There's much more on stents at the U.S. Food and Drug Administration.



SOURCES: Nico H. J. Pijls, M.D., Ph.D., professor, cardiology, Catharina Hospital, Eindhoven, the Netherlands; Stephen G. Ellis, M.D., director, cardiac catheterization laboratory, Cleveland Clinic; Jan. 16, 2009, New England Journal of Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Blood Emergency: Blood Supply Tips Into Danger Zone
2. University of Ottawa Heart Institute Scientists Successfully Develop Novel Biomaterial to Help Grow New Blood Vessels
3. Doctors Re-Examine Blood Thinners to Prevent Strokes
4. Seventeen Months After Cord Blood Transplant - Child is Free of Signs of Cancer
5. Penn researchers unlock molecular origin of blood stem cells
6. OHSU School of Dentistry team discovers new molecule in blood-pressure control system
7. Donate Blood Today -- Save Up to Three Lives
8. Viagra May Shield Heart From Blood Pressure Damage
9. Blood Drive Held in Honor of Gloucester City Resident - Evan Goldglantz
10. Young blood fights cancer
11. Rising Blood Sugar May Harm the Aging Brain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Blood Flow Measurement Boosts Stent Outcomes
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
Breaking Medicine Technology: